Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-01-19 Meisner Derek M Chief Legal Officer & Corp Sec Sale 10b5-1 −8,933 $3.48 $31K 108,867
2024-01-18 Zuga Matt CFO & Chief Business Officer Sale 10b5-1 −4,242 $3.71 $16K 211,445
2024-01-18 Siemers Eric Chief Medical Officer Sale 10b5-1 −3,124 $3.71 $12K 117,576
2024-01-18 Barton Russell Chief Operating Officer Sale 10b5-1 −2,833 $3.73 $11K 96,867
2023-08-17 Ives Jeffrey L. Director Sale 10b5-1 −39,149 $6.48 $254K 0
2023-08-17 Ives Jeffrey L. Director Sale 10b5-1 −2,800 $6.66 $19K 0

Page 4 of 4 · 66 trades